Search for: "U.S. v. Neal*"
Results 1 - 20
of 491
Sort by Relevance
|
Sort by Date
30 May 2024, 10:50 am
Senior U.S. [read post]
27 May 2024, 4:00 pm
The case was Warner Chappell v. [read post]
15 May 2024, 7:41 am
Smith Corp., 521 U.S. 179, 191 (1997), citing Connors v. [read post]
14 May 2024, 6:00 am
In Bissonnette v. [read post]
13 May 2024, 9:11 am
., et al. v. [read post]
13 May 2024, 6:07 am
SEC, 568 U.S. 442 (2013) (holding that the discovery rule does not apply to the statute of limitations for civil penalty actions brought by the Securities and Exchange Commission under the Investment Advisers Act of 1940); Rotkiske v. [read post]
10 May 2024, 12:57 pm
Yesterday, the U.S. [read post]
10 May 2024, 6:30 am
U.S. [read post]
9 May 2024, 4:33 pm
In a landmark decision, the U.S. [read post]
9 May 2024, 10:55 am
Metro-Goldwyn-Mayer, Inc., 572 U.S. 663 (2014). [read post]
9 May 2024, 9:19 am
The U.S. [read post]
9 May 2024, 9:19 am
The U.S. [read post]
9 May 2024, 7:02 am
Access today’s rulings of the U.S. [read post]
1 May 2024, 11:52 am
Mackenzie, 138 U.S. 252 (1891). [read post]
25 Apr 2024, 3:16 pm
Former U.S. [read post]
18 Apr 2024, 10:12 am
Compare Caraballo-Caraballo v. [read post]
13 Apr 2024, 3:33 pm
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
22 Mar 2024, 4:00 am
Unfortunately, these steps are set forth over bloated rules which span approximately 140,000 words, more than twice the approximately 60,000 words set forth in the better developed and thought-out U.S. [read post]
18 Mar 2024, 7:22 pm
But the U.S. [read post]
